Skip to main content
Mark Winters, MD, Family Medicine, Virginia Beach, VA

MarkRWintersMD

Family Medicine Virginia Beach, VA

TPMG Southside Medical Director

Dr. Winters is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Winters' full profile

Already have an account?

  • Office

    4421 Virginia Beach Blvd
    Ste 106
    Virginia Beach, VA 23462
    Phone+1 757-343-1227

Summary

  • Dr. Mark Winters is a family physician in Virginia Beach, VA. He received his medical degree from Vanderbilt University School of Medicine and was in practice 36 years. He is experienced in hypertension, sports medicine, diabetes mellitus, clinical trials and medical-legal work. In 2019 he was honored as the ‘Virginia Beach Physician of the Year’. In 2020 he assumed the role of TPMG’s Southside Medical Director.

Education & Training

  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Family Medicine, 1980 - 1983
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1980

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1981 - 2024
  • American Board of Family Medicine Family Medicine
  • American Academy of Family PhysiciansFellow of the American Academy of Family Physicians

Awards, Honors, & Recognition

  • Virginia Beach Physician of the Year John J. Krueger MD Foundation, 2019
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
  • Diabetes Recognition Program National Committee for Quality Assurance, 2010-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

Journal Articles

  • Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial  
    Levy, American Journal of Hypertension, 2/1/2004

Professional Memberships